Importance of Dairy Products in Cardiovascular Diseases and Type 2 Diabetes

Critical Reviews in Food Science and Nutrition

Volumn 53, Issue 9, 2013, Pages 902-908

  Yerlikaya, O ^a   Acu, M ^a   Kinik, O ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Cardiovascular diseases; dairy products; nutrition; type 2 diabetes

Indexed keywords

CARDIO-VASCULAR DISEASE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ECONOMIC BURDEN; ENDOCRINE DISORDERS; RENAL FAILURE; TYPE-2 DIABETES;

DAIRY PRODUCTS; NUTRITION; CARDIOLOGY;

DISEASES;

FATTY ACID; TRANS FATTY ACID;

ANALYSIS; CARDIOVASCULAR DISEASES; COMPLICATION; DAIRY PRODUCT; DIABETES MELLITUS, TYPE 2; DIET; HUMAN; LIFESTYLE; PRIMARY PREVENTION; RISK FACTOR; CARDIOVASCULAR DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

CARDIOVASCULAR DISEASES; DAIRY PRODUCTS; DIABETES MELLITUS, TYPE 2; DIET; FATTY ACIDS; HUMANS; LIFE STYLE; PRIMARY PREVENTION; RISK FACTORS; TRANS FATTY ACIDS;

EID: 84879542272     PISSN: 10408398     EISSN: 15497852     Source Type: Journal    
DOI: 10.1080/10408398.2011.572200     Document Type: Article

References (80)

1. Abbott, R. D., Curb, J. D., Rodriguez, B. L., Sharp, D. S., Burchfiel, C. M. and Yano, K. 1996. Effect of dietary calcium and milk consumption on risk of thromboembolic stroke in older middle-aged men: The Honolulu Heart Program. Stroke, 27: 813-818.
2. Adeghate, E., Schattner, P. and Dunn, E. 2006. An update on the etiology and epidemiology of diabetes mellitus. Ann. NY. Acad. Sci., 1084: 1-29.
3. Agerholm-Larsen, L., Raben, A., Haulnik, N., Hansen, A. S., Manders, M. and Astrup, A. 2000. Effect of eight week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur. J. Clin. Nutr., 54: 288-289.
4. Anonymous. 2010. What is diabetes? Available from http://www.tip2diyabet.com/tip2-diyabet.html. Accessed Feb. 1, 2010
5. Anonymous. 2011. Treatment methods of type-diabetes. Available from http://www.mailce.com/tip-2-diyabet-tedavisi.html. Accessed January 16, 2011
6. Apostolidis, E., Kwon, Y. I. and Shetty, K. 2006. Potential of select yogurts for diabetes and hypertension management. J. Food Biochem., 30: 699-717.
7. Ascherio, A., Hennekens, C. and Willett, W. C. 1996. Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension, 27 (5): 1065-1072.
8. Bantle, J. P., Wylie-Rosett, J., Albright, A. L., Apovian, C. M., Clark, N. G., Franz, M. J., Hoogwerf, B. J., Lichtenstein, A. H., Mayer-Davis, E., Mooradian, A. D. and Wheeler, M. L. 2008. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care, 31 (Suppl. 1): 61-78.
9. Benalla, W., Bellahcen, S. and Bnouham, M. 2010. Antidiabetic medicinal plants as a source of alpha glucosidase inhibitors. Curr. Diabetes Rev., 6 (4): 247-254.
10. Bischoff, H. 1994. Pharmacology of alpha-glucosidase inhibition. Eur. J. Clin. Invest., 24 (Suppl. 3): 3-10.
11. Bostick, R. M., Kushi, L. H., Wu, Y., Meyer, K. A., Sellers, T. A. and Folsom, A. R. 1999. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am. J. Epidemiol., 149: 151-161.
12. Chi, D., Nakano, M. and Yamamoto, K. 2004. Milk and milk products consumption in relationship to serum lipid levels: A community-based study of middle-aged and, older population in Japan. Cent. Eur. J. Public Health, 12: 84-87.
13. Choi, H. K., Willett, W. C., Stampfer, M. J., Rimm, E. and Hu, F. B. 2005. Dairy consumption and risk of type 2 diabetes mellitus in men: A prospective study. Arch. Intern. Med., 165: 997-1003.
14. Coşkun, T. 2006. Pro-, pre- and symbiotics. J. Child Health Dis., 49: 128-148.
15. Djomeni, P. D. D., Tédong, L., Asongalem, E. A., Dimo, T., Sokeng, S. D. and Kamtchouing, P. 2006. Hypoglycaemic and antidiabetic effect of root extracts of Ceiba pentadra in normal and diabetic rats. Afr. J. Tradit. Complem., 3: 129-136.
16. Duengler, F., Torremochal, F., Yameogo, M., Marechaud, R. and Hadjadj, S. 2006. Effect of dietary calcium intake on weight gain in type 2 diabetic patients following initiation of insulin therapy. Diabetes Metab., 32: 358-363.
17. Elwood, P. C., Pickering, J. E., Fehily, A. M., Hughes, J. and Ness, A. R. 2004. Milk drinking, ischaemic heart disease and ischaemic stroke I. Evidence from the Caerphilly cohort. Eur. J. Clin. Nutr., 58: 711-717.
18. FitzGerald, R. J. and Meisel, H. 2000. Milk protein derived inhibitors of angiotensin-I-converting enzyme. Br. J. Nutr., 84: S33-S37.
19. Fujita, H., Yamagami, T. and Ohshima, K. 2003. Long-term ingestion of touchi-extract, an α-glucosidase inhibitor, by borderline and mild type-2 diabetic subjects is safe and significantly reduces blood glucose levels. Nutr. Res., 23: 713-722.
20. Gotcheva, V., Hristozova, E., Hristozova, T., Guo, M., Roshkova, Z. and Angelov, A. 2002. Assessment of potential probiotic properties of lactic acid bacteria and yeast strains. Food Biotechnol., 16 (3): 221-225.
21. Harris, W. S., Park, Y. and Isley, W. L. 2003. Cardiovascular disease and long-chain omega-3 fatty acids. Curr. Opin. Lipidol., 14: 9-14.
22. Haque, E., Chand, R. and Kapila, S. 2009. Biofunctional properties of bioactive peptides of milk origin. Food Rev. Int., 25: 28-43.
23. Haug, A., Hallaq, H. and Leaf, A. 1992. " Potential antiatherogenic effects of omega-3 fatty acids ". In Thrombosis: An Update, Edited by: Neri Serneri, G. G., Gensini, G. F., Abbate, R. and Prisco, D. 361-372. Florence: Scientific Press.
24. Haug, A., Høstmark, A. T. and Harstad, O. M. 2007. Bovine milk in human nutrition-a review. Lipids Health Dis., 6: 25
25. Hayes, K., Pronczuk, A. and Perlman, D. 2001. Vitamin E in fortified cow milk uniquely enriches human plasma lipoproteins. Am. J. Clin. Nutr., 74: 211-218.
26. Hegsted, D. M., Ausman, L. M., Johnson, J. A. and Dallal, G. E. 1993. Dietary fat and serum lipids. Am. J. Clin. Nutr., 57: 875-883.
27. Hu, F. B., van Dam, R. M. and Liu, S. 2001. Diet and risk of Type II diabetes: The role of types of fat and carbohydrate. Diabetologia, 44: 805-817.
28. Inzucchi, S. E. 2002. Oral antihyperglycemic therapy for type 2 diabetes. Scientific review. JAMA-J. Am. Med. Assoc., 287: 360-372.
29. Iso, H., Stampfer, M. J. and Manson, J. E. 1999. Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke, 30: 1772-1779.
30. Ji, F., Xiao, G., Dong, L., Ma, Z. and Ni, J. 2010. Development of alpha-glucosidase inhibitor from medicinal herbs. China J. Chinese Materia Medica., 35 (12): 1633-1640.
31. Kelemen, L. E., Kushi, L. H., Jacobs, D. R. Jr. and Cerhan, J. R. 2005. Associations of dietary protein with disease and mortality in a prospective study of postmenopausal women. Am. J. Epidemiol., 161: 1239-1249.
32. Kim, Y. M., Jeong, Y. K., Wang, M. H., Lee, W. Y. and Rhee, H. I. 2005. Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia. Nutrition, 21: 756-775.
33. King, H., Aubert, R. E. and Herman, W. H. 1998. Global burden of diabetes 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care, 21: 1414-1431.
34. Knowler, M. D., Barrett-Connor, E., Fowler, S. E., Hamman, R. F., Lachin, J. M., Walker, E. A. and Nathan, D. M. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med., 346: 393-403.
35. Korhonen, H. and Pihlanto-Leppälä, A. 2006. Bioactive peptides: Production and functionality. Int. Dairy J., 16: 945-960.
36. Kris-Etherton, P. M. 2010. Trans-fats and coronary heart disease. Crit. Rev. Food Sci., 50: 29-30.
37. Kris-Etherton, P. M., Pearson, T. A., Wan, Y., Hargrove, R. L., Moriarty, K., Fishell, V. and Etherton, T. D. 1999. High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am. J. Clin. Nutr., 70: 1009-1015.
38. Lee, H. M. and Lee, Y. 2008. A differential medium for lactic acid-producing bacteria in a mixed culture. Letters in App. Microbiol., 46: 676-681.
39. Meijer, G. W., van Tol, A., van Berkel, T. J. and Weststrate, J. A. 2001. Effect of dietary elaidic versus vaccenic acid on blood and liver lipids in the hamster. Atherosclerosis, 157: 31-40.
40. Mennen, L. I., Balkau, B. and Vol, S. 1999. Tissue-type plasminogen activator antigen and consumption of dairy products: The DESIR Study: data from an epidemiological study on insulin resistance syndrome. Thromb Res., 94: 381-388.
41. Mennen, L. I., Lafay, L., Feskens, E. J. M., Novak, M., Lépinay, P. and Balkau, B. 2000. Possible protective effect of bread and dairy products on the risk of the metabolic syndrome. Nutrition Research, 20: 335-347.
42. Mensink, M. 2005. Lifestyle intervention, glucose tolerance, and risk of developing type 2 diabetes mellitus. Metab. Syndr. Relat. Disord., 3: 26-34.
43. Mensink, R. 2006. Dairy products and the risk to develop type 2 diabetes or cardiovascular disease. Int. Dairy J., 16: 1001-1004.
44. Mensink, R. P. and Katan, M. B. 1992. Effect of dietary fatty acids on serum lipids and lipoproteins: A metaanalysis of 27 trials. Arterioscler. Thromb., 12: 911-919.
45. Mensink, R. P., Zock, P. L., Kester, A. D. M. and Katan, M. B. 2003. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clinical Nutr., 77: 1146-1155.
46. Miller, G. D., Jarvis, J. K. and McBean, L. D. 1999. Handbook of Dairy Foods and Nutrition, 2nd ed., Boca Raton: CRC Press.
47. Mohan, J. C., Arora, R. and Khalilullah, M. 1990. Short-term hypolipidemic effects of oral Lactobacillus sporogenes therapy in patients with primary dyslipidemias. Indian Heart J., 42: 361-364.
48. Molkentin, J. 2000. Occurrence and biochemical characteristics of natural bioactive substances in bovine milk lipids. Br. J. Nutr., 84: 47-53.
49. Montonen, J., Knekt, P., Tärkänen, T., Jävinen, R., Heliövaara, M., Aroma, A. and Reunanen, A. 2005. Dietary patterns and the incidence of type 2 diabetes. Am. J. Epidemiol., 161: 219-227.
50. Mozaffarian, D., Katan, M. E., Ascherio, A., Stampfer, M. J. and Willett, W. C. 2006. Trans fatty acids and cardiovascular disease. N. Engl. J. Med., 354: 1601-1613.
51. Ness, A. R., Smith, G. D. and Hart, C. 2001. Milk, coronary heart disease and mortality. J. Epidemiol. Community Health, 55: 379-382.
52. Nestel, P. J., Chronopulos, A. and Cehun, M. 2005. Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolaemic subjects. Eur. J. Clinical Nutr., 59: 1059-1063.
53. Pan, X. R., Li, G. W. and Hu, Y. H. 1997. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care, 20: 537-544.
54. Pfeuffer, M. and Schrezenmeir, J. 2006. Diagnostic in obesity comorbidities, milk and metabolic syndrome. Obesity Reviews, 8: 109-118.
55. Ramchandran, L. and Shah, N. P. 2008. Proteolytic profiles and angiotensin-I converting enzyme and alpha-glucosidase inhibitory activities of selected lactic acid bacteria. J. Food Sci., 73 (2): M75-M81.
56. Ramchandran, L. and Shah, N. P. 2009. Effect of exopolysaccharides and inulin on the proteolytic, angiotensin-I-converting enzyme- and α-glucosidase-inhibitory activities as well as on textural and rheological properties of low-fat yogurt during refrigerated storage. Dairy Sci. Technol., 89: 583-600.
57. Ramchandran, L. and Shah, N. P. 2010. Influence of addition of Raftiline HP® on the growth, proteolytic, ACE- and α-glucosidase inhibitory activities of selected lactic acid bacteria and Bifidobacterium. LWT-Food Sci. Tech., 43: 146-152.
58. Regazzo, D., Da Dalt, L., Lombardi, A., Andrighetto, C., Negro, A. and Gabai, G. 2010. Fermented milks from Enterococcus faecalis TH563 and Lactobacillus delbrueckii subsp. bulgaricus LA2 manifest different degrees of ACE-inhibitory and immunomodulatory activities. Dairy Sci. Technol., 90: 469-476.
59. Rogelj, I. 2000. Milk, dairy products, nutrition and health. Food Technol. Biotechnol., 38 (2): 143-147.
60. Rosell, M., Johansson, G., Berglund, L., Vessby, B., de Faire, U. and Hellénius, M-L. 2004. Associations between the intake of dairy fat and calcium and abdominal obesity. Int. J. Obesity, 28: 1427-1434.
61. Rudkowska, I. 2009. Functional foods for health: Focus on diabetes. Maturitas, 62: 263-269.
62. Rybka, J., Goke, B. and Sissman, J. 1998. European comparative study of 2 alpha-glucosidase inhibitors, miglitol and acarbose (abstract). Diabetes, 48 (Suppl. 1): 101
63. Sarkar, S. 2008. Effect of probiotics on biotechnological characteristics of yoghurt. Brit. Food J., 110 (7): 717-740.
64. Sjogren, P., Rosell, M., Skoglund-Andersson, C., Zdravkovic, S., Vessby, B., de Faire, U., Hamsten, A., Hellenius, M. L. and Fisher, R. M. 2004. Milk-derived fatty acids are associated with a more favorable LDL particle size distribution in healthy men. J. Nutr., 134: 1729-1735.
65. Staff, A. C., Holven, K., Løken, E. B., Sygnestveit, K., Vollset, S. E. and Smeland, S. 2005. Does folic acid have effects on other health problems than neural tube defects?. Tidsskr Nor Laegeforen, 125: 438-441.
66. Steijns, J. M. 2008. Dairy products and health: Focus on their constituents or on the matrix?. Int. Dairy J., 18: 425-435.
67. Taranto, M. P., Medici, M., Perdigon, G., Ruiz Holgado, A. P. and Valdez, G. F. 1998. Evidence for hypocholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J. Dairy Sci., 81: 2336-2340.
68. Tholstrup, T. 2006. Dairy products and cardiovascular disease. Curr. Opin. Lipidol., 17: 1-10.
69. Tholstrup, T., Høy, C.-E., Normann Andersen, L., Christensen, R. D. K. and Sandstro, M. B. 2004. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently?. J. Am. Coll. Nutr., 23: 169-176.
70. Tholstrup, T., Raff, M., Basu, S., Nonboe, P., Sejrsen, K. and Straarup, E. M. 2006. Effects of butter high in ruminant trans and monounsaturated fatty acids on lipoproteins, incorporation of fatty acids into lipid classes, plasma C-reactive protein, oxidative stress, hemostatic variables, and insulin in healthy young men. Am. J. Clin. Nutr., 83: 237-243.
71. Thorsdottir, I., Hill, J. and Ramel, A. 2004. Omega-3 fatty acid supply from milk associates with lower type 2 diabetes in men and coronary heart disease in women. Prev. Med., 39: 630-634.
72. Tricon, S., Burdge, G. C., Jones, E. L., Russell, J. J., El-Khazen, S., Moretti, E., Hall, W. L., Gerry, A. B., Leake, D. S., Grimble, R. F., Williams, C. M., Calder, P. C. and Yaqoob, P. 2006. Effects of dairy products naturally enriched with cis-9, trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men. Am. J. Clin. Nutr, 83: 744-753.
73. Tsuda, H., Sakine, K., Ushida, Y., Kuhara, T., Takasuka, N., Ligo, M., Han, B. S. and Moore, M. A. 2000. Milk and dairy products in cancer prevention: Focus on bovine lactoferrin. Mutat. Res., 242: 227-233.
74. Tuomilehto, J., Korhonen, H. J., Kartovaara, L., Salomaa, V., Stengard, J. H., Pitkanen, M., Aro, A., Javela, K., Uusitupa, M. and Pitkäniemi, J. 1991. Prevalence of diabetes mellitus and impaired glucose tolerance in the middle aged population of three areas in Finland. Int. J. Epidemiol., 20: 1010-1017.
75. Ursin, G., Ziegler, R. G. and Subar, A. F. 1993. Dietary patterns associated with a low-fat diet in the national health examination follow-up study: Identification of potential confounders for epidemiologic analyses. Am. J. Epidemiol., 137: 916-927.
76. Virtanen, S. M. and Aro, A. 2008. Dietary factors in the aetiology of diabetes. Ann. Med., 26: 469-478.
77. Willett, W. C., Stampfer, M. J., Manson, J. E., Colditz, G. A., Speizer, F. E., Rosner, B. A., Sampson, L. A. and Hennekens, C. H. 1993. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet, 341: 581-585.
78. Witteman, J. C., Willett, W. C. and Stampfer, M. J. 1989. A prospective study of nutritional factors and hypertension among US women. Circulation, 80: 1320-1327.
79. Yadav, H., Jain, S. and Sinha, P. R. 2007. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition, 23: 62-68.
80. Yamamoto, N., Ejiri, M. and Mizuno, S. 2003. Biogenic peptides and their potential use. Curr. Pharm. Design., 9: 1345-1355.